tiprankstipranks
Amicus Therapeutics Posts Robust 2024 Financial Growth
PremiumCompany AnnouncementsAmicus Therapeutics Posts Robust 2024 Financial Growth
3d ago
Amicus Therapeutics: Promising Growth and Strong Financial Guidance Justify Buy Rating
Premium
Ratings
Amicus Therapeutics: Promising Growth and Strong Financial Guidance Justify Buy Rating
3d ago
Amicus files automatic mixed securities shelf
Premium
The Fly
Amicus files automatic mixed securities shelf
3d ago
FOLD Earnings this Week: How Will it Perform?
PremiumPre-EarningsFOLD Earnings this Week: How Will it Perform?
6d ago
Amicus reports preliminary FY24 revenue of $528M, consensus $526.12M
Premium
The Fly
Amicus reports preliminary FY24 revenue of $528M, consensus $526.12M
1M ago
Amicus downgraded to Equal Weight from Overweight at Morgan Stanley
Premium
The Fly
Amicus downgraded to Equal Weight from Overweight at Morgan Stanley
2M ago
Amicus price target raised to $15 from $13 at Guggenheim
PremiumThe FlyAmicus price target raised to $15 from $13 at Guggenheim
4M ago
Amicus price target raised to $21 from $19 at UBS
Premium
The Fly
Amicus price target raised to $21 from $19 at UBS
4M ago
Amicus Therapeutics Reports Strong Q3 2024 Growth
Premium
Company Announcements
Amicus Therapeutics Reports Strong Q3 2024 Growth
4M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100